amiloride
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
FDA Office of Orphan Products Development
Overview
amiloride is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
amiloride clinical trials
Explore related
Medical disclaimer. This page summarizes research about amiloride for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.